Acticor biotech
Safe and effective treatment of stroke
Acticor biotech has raised €155M across 2 funding rounds from 2 investors, most recently a Series B round in Nov 2018. Based in Paris, France; founded 2013; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€155M
€154,500,000
Funding rounds
2
Investors
2
distinct backers
Active since
2017-02
latest 2018-11
Funding by year
EUR raised per yearActicor biotech — funding by year — interactive chart.
Data table
| Acticor biotech — funding by year | |
|---|---|
| 2017 | €1.5M |
| 2018 | €153M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-11-19 | Series B | €153M | Newton Biocapital | View deal → |
| 2017-02-01 | Early VC | €1.5M | CapDecisif Management | View deal → |
Investors
2Related news
Similar companies
same sector, similar size- Sparingvision€135MFrance · Healthtech
- WiThings€77MFrance · Healthtech
- Vivet Therapeutics€83MFrance · Healthtech
- TreeFrog Therapeutics€71MFrance · Healthtech
- Diabeloop€115MFrance · Healthtech
- Amolyt Pharma€129MFrance · Healthtech
Global coverage: FundingData